Dublin, Feb. 06, 2017 -- Research and Markets has announced the addition of the "Point of Care Diagnostics" report to their offering.
This study will describe the market for POC diagnostics at the global level. It focuses on the accelerating growth in this important diagnostic market segment and the key industry players.
Specifically, the report will discuss market influences in the industry and predict the changes that will shape the future POC market. This includes breakdowns for U.S. markets, product segments and the continuous updating of POC products and a review of the business activities of market leaders.
Scope of the Report:
- An overview of the global markets for point of care diagnostics.
- Analyses of global market trends, with data from 2014 and 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Discussion of factors driving the market including staff shortages, older populations, long-term cost savings, and need for faster diagnosis and care.
- A look at how availability of POC testing has revolutionized the continuum of the patient-care process.
- In depth analysis of the major force driving the growth of this industry, the effort to provide better patient care by improving the turn-around-time (TAT) that POC testing offers.
- A look at the other market factors including growth restraints and opportunities.
- Profiles of major players in the industry.
Specifically, the report:
- Describes the POC industry.
- Estimates the current and future market size.
- Provides breakdowns for U.S. markets.
- Describes product segments and the continuous updating of POC products.
- Analyzes market influences in the industry and predicts the changes that will shape the future POC market.
- Discusses trends within the market and provides a future outlook.
- Reviews business activities of market leaders.
- Lists patents for POC technologies.
Companies Mentioned:
- Abaxis Inc.
- Abbott Laboratories
- Alere Inc.
- Beckman Coulter Inc.
- Becton, Dickinson And Co.
- Chembio Diagnostics Inc.
- Church & Dwight Co. Inc.
- Danaher Corp.
- Hemocue AB
- International Technidyne Corp.
- Johnson & Johnson
- Nova Biomedical
- Orasure Technologies
- Phamatech Inc.
- Quidel Corp.
- Radiometer Medical APS
- Roche
- Sa Scientific Ltd.
- Sekisui Diagnostics
- Siemens Medical Solutions
- Trividia Health Inc.
- Trinity Biotech Plc
Key Topics Covered:
1: Introduction
2: Summary
3: Industry Overview
4: The Global POC Market
5: Blood Chemistry And Electrolyte Testing
6: Cardiac Marker Testing
7: Cholesterol Testing
8: Drug And Alcohol Abuse Testing
9: Glucose Testing
10: Infectious Disease Testing
11: Pregnancy And Fertility Testing
12: Hemoglobin/Hemostasis Testing
13: Tumor Marker Testing
14: Urine Chemistry Testing
15: Other POC Testing
16: Technology Applications
17: Global POC Market
18: Profiles Of Major Market Participants
19: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/plmq7v/point_of_care
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Point-of-Care Diagnostics


Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Italy Fines Apple €98.6 Million Over App Store Dominance
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



